HKSE:01177 (Hong Kong)  
Sino Biopharmaceutical Ltd logo

Sino Biopharmaceutical Ltd

HK$ 4.51 (+4.4%) Nov 29
On watch
P/E:
N/A
P/B:
2.41
Market Cap:
HK$ 84.85B ($ 10.86B)
Enterprise V:
HK$ 80.86B ($ 10.35B)
Volume:
58.93M
Avg Vol (2M):
51.23M
Also Trade In:
Volume:
58.93M
Market Cap HK$:
84.85B
Market Cap $:
10.86B
PE Ratio:
N/A
Avg Vol (2-Month):
51.23M
Enterprise Value HK$:
80.86B
Enterprise Value $:
10.35B
PB Ratio:
2.41
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$)
EPS (TTM) (HK$) 0
Beta 0.66
Volatility % 27.33
14-Day RSI 57.66
14-Day ATR (HK$) 0.20807
20-Day SMA (HK$) 4.372
12-1 Month Momentum % -29.79
52-Week Range (HK$) 3.58 - 6.3
Shares Outstanding (Mil) 18,813.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sino Biopharmaceutical Ltd Filings

Document Form Filing Date
No Filing Data

Sino Biopharmaceutical Ltd Analysis

Share your research